A detailed history of Stonebridge Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stonebridge Capital Advisors LLC holds 1,722 shares of ABBV stock, worth $309,960. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,722
Previous 1,823 5.54%
Holding current value
$309,960
Previous $312,000 8.97%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $16,547 - $20,132
-101 Reduced 5.54%
1,722 $340,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $44,269 - $51,697
-286 Reduced 13.56%
1,823 $312,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $34,201 - $38,969
214 Added 11.29%
2,109 $384,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $550 - $619
4 Added 0.21%
1,895 $293,000
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $21,240 - $24,589
-159 Reduced 7.76%
1,891 $281,000
Q2 2023

Aug 23, 2023

SELL
$132.51 - $164.9 $32,332 - $40,235
-244 Reduced 10.64%
2,050 $276,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $8.61 Million - $9.91 Million
-59,526 Reduced 96.29%
2,294 $365,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $217,561 - $260,913
1,573 Added 2.61%
61,820 $10 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $80,526 - $92,358
600 Added 1.01%
60,247 $8.09 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $6.9 Million - $8.77 Million
-50,108 Reduced 45.65%
59,647 $9.14 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $255,381 - $316,856
-1,935 Reduced 1.73%
109,755 $17.8 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $434,769 - $550,108
4,047 Added 3.76%
111,690 $15.1 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $118,210 - $134,186
1,111 Added 1.04%
107,643 $11.6 Million
Q2 2021

Aug 20, 2021

BUY
$105.21 - $117.21 $466,290 - $519,474
4,432 Added 4.34%
106,532 $12 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $223,832 - $246,412
2,188 Added 2.19%
102,100 $11 Million
Q4 2020

Mar 05, 2021

SELL
$80.49 - $108.67 $34,771 - $46,945
-432 Reduced 0.43%
99,912 $10.7 Million
Q3 2020

Nov 18, 2020

SELL
$85.91 - $100.83 $70,875 - $83,184
-825 Reduced 0.82%
100,344 $8.79 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $114,237 - $152,866
-1,557 Reduced 1.52%
101,169 $9.93 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $77,851 - $118,032
1,207 Added 1.19%
102,726 $7.83 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $205,570 - $257,212
2,850 Added 2.89%
101,519 $8.99 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $380,525 - $457,500
6,042 Added 6.52%
98,669 $7.47 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $152,358 - $194,749
2,319 Added 2.57%
92,627 $6.74 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $401,205 - $472,198
5,201 Added 6.11%
90,308 $7.28 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $283,062 - $349,092
3,636 Added 4.46%
85,107 $7.85 Million
Q3 2018

Nov 15, 2018

SELL
$88.91 - $98.84 $31,918 - $35,483
-359 Reduced 0.44%
81,471 $7.71 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $204,339 - $241,779
2,276 Added 2.86%
81,830 $7.58 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $670,660 - $898,077
-7,289 Reduced 8.39%
79,554 $7.53 Million
Q4 2017

Feb 15, 2018

SELL
$89.56 - $98.21 $2.16 Million - $2.37 Million
-24,142 Reduced 21.75%
86,843 $8.4 Million
Q3 2017

Nov 15, 2017

SELL
$69.85 - $89.22 $113,506 - $144,982
-1,625 Reduced 1.44%
110,985 $9.86 Million
Q2 2017

Aug 15, 2017

BUY
N/A
112,610
112,610 $8.17 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.